Use of rotigotine for the treatment or prevention of dopaminergic neurone loss

Details for Australian Patent Application No. 2004308648 (hide)

International Classifications

Event Publications

13 July 2006 PCT application entered the National Phase

PCT publication WO2005/063237 Priority application(s): WO2005/063237

25 November 2010 Alteration of Name

The name of the applicant has been altered to UCB Pharma GmbH Amendments

16 December 2010 Application Accepted

Published as AU-B-2004308648

14 April 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.